Momenta Pharmaceuticals, Inc. (MNTA)

[floblu14]

....MNTA can use some of its cash horde to fund an M-Copax clinical trial.

From Dew's post -

This has been asked and answered on several occasions. The simple and direct answer is that the FDA accepted NVS/MNTA’s Copaxone application for review under the 505j (ANDA) regulatory pathway.

....the whole point of the 505j regulatory pathway is to allow generic drugs to come to market without clinical trials....